These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2944123)

  • 1. Genetic characterization of the mutagenic activity of environmental chemicals at specific loci in two-component heterokaryons of Neurospora crassa.
    de Serres FJ; Brockman HE
    Prog Clin Biol Res; 1986; 209A():209-18. PubMed ID: 2944123
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of Neurospora in the evaluation of the mutagenic activity of environmental chemicals.
    de Serres FJ
    Environ Mutagen; 1983; 5(3):341-51. PubMed ID: 6221926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The testing of 4CMB, 4HMB and BC for mutagenicity in a new Neurospora crassa heterokaryon.
    Luker MA
    Mutat Res; 1982; 100(1-4):123-6. PubMed ID: 6460177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the spot, plate and suspension test systems for the detection of the mutagenicity of environmental agents and chemical carcinogens in Neurospora crassa.
    Ong TM
    Mutat Res; 1978 Jun; 53(3):297-308. PubMed ID: 149924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation tests in Neurospora crassa. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Brockman HE; de Serres FJ; Ong TM; DeMarini DM; Katz AJ; Griffiths AJ; Stafford RS
    Mutat Res; 1984 Mar; 133(2):87-134. PubMed ID: 6231482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity of neocarzinostatin in Neurospora crassa.
    DeGraff WG
    Mutat Res; 1984 Sep; 128(2):127-35. PubMed ID: 6236365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa.
    Ong T; Slade B; de Serres FJ
    J Environ Pathol Toxicol; 1979; 2(4):1109-18. PubMed ID: 156240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa.
    Ong T; Slade B
    J Toxicol Environ Health; 1978; 4(5-6):815-24. PubMed ID: 153406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the cytotoxic and mutagenic effects of selected mutagens on excision repair-sufficient and -deficient AD-3 mutants of Neurospora crassa.
    Ong T; Converse JO
    Mutat Res; 1983 Oct; 124(1):61-7. PubMed ID: 6226873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of the specific-locus assay in the ad-3 region of two-component heterokaryons of Neurospora for risk assessment of environmental chemicals.
    de Serres FJ
    Mutat Res; 1991; 250(1-2):251-74. PubMed ID: 1834935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic evaluation of antischistosomal drugs and their derivatives in Neurospora crassa.
    Ong T; de Serres FJ
    J Toxicol Environ Health; 1975 Nov; 1(2):271-9. PubMed ID: 128637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two N-hydroxylaminopurines are highly mutagenic in the ad-3 forward-mutation test in growing cultures of heterokaryon 12 of Neurospora crassa.
    Brockman HE; de Serres FJ; Ong TM; Hung CY
    Mutat Res; 1987 Mar; 177(1):61-75. PubMed ID: 2950320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microbiological short-time tests for the evaluation of mutagenic potential of chemical substances].
    Gericke D
    Naturwissenschaften; 1983 Apr; 70(4):173-9. PubMed ID: 6222262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity of chemical carcinogens in Neurospora crassa.
    Ong TM; De Serres FJ
    Cancer Res; 1972 Sep; 32(9):1890-3. PubMed ID: 4264527
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxicity and mutagenicity of cis platin assayed in neurospora.
    Pope S; Parish JH
    Carcinogenesis; 1984 Aug; 5(8):1105-6. PubMed ID: 6235055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the spectra of genetic damage in formaldehyde-induced ad-3 mutations between DNA repair-proficient and -deficient heterokaryons of Neurospora crassa.
    de Serres FJ; Brockman HE
    Mutat Res; 1999 Sep; 437(2):151-63. PubMed ID: 10556619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of Neurospora in detecting agents that cause aneuploidy.
    Griffiths AJ; Brockman HE; DeMarini DM; de Serres FJ
    Mutat Res; 1986; 167(1-2):35-45. PubMed ID: 2934630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the uvs-2 allele of Neurospora crassa on the mutagenic potency of two N-hydroxylaminopurines and 2-aminopurine in the ad-3 forward-mutation test.
    Brockman HE; de Serres FJ; Hung CY; Ong T
    Mutat Res; 1989 Jul; 218(1):1-11. PubMed ID: 2526296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a specific-locus assay in the ad-3 region of two-component heterokaryons of Neurospora: a review.
    de Serres FJ
    Environ Mol Mutagen; 1992; 20(4):225-45. PubMed ID: 1425606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the mutagenicity and mutagen specificity of ethylenimine with triethylenemelamine in the ad-3 region of heterokaryon 12 of Neurospora crassa.
    de Serres FJ; Malling HV; Ong TM
    Mutat Res; 1995 May; 328(2):193-205. PubMed ID: 7739603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.